Tech Journal of Colorado
SEE OTHER BRANDS

Get your fresh news on science and technology in Colorado

Tech Journal of Colorado: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.

Press releases published on May 5, 2025

Suzy Founder & CEO Matt Britton Launches Generation AI

Suzy Founder & CEO Matt Britton Launches Generation AI

NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Suzy, the leading end‑to‑end consumer insights platform, today announced that its Founder and CEO, Matt Britton, will release his highly anticipated second book published by Wiley, Generation AI: Why Generation …

Justice Bid Secures Strategic Investment From OnDean Forward’s Legal Technology Fund

Justice Bid Secures Strategic Investment From OnDean Forward’s Legal Technology Fund

$4 Million Backing Accelerates Justice Bid’s Ability to Fill Market Gap For Enterprises – Ensure Transparency And ROI Clarity for Outside Counsel Selection CHICAGO, May 05, 2025 (GLOBE NEWSWIRE) -- Justice Bid, the leading solution provider that delivers …

DN Miner Empowers Crypto Investors with Risk-Offsetting Cloud Mining Strategies Amid Market Momentum

DN Miner Empowers Crypto Investors with Risk-Offsetting Cloud Mining Strategies Amid Market Momentum

London, UK , May 05, 2025 (GLOBE NEWSWIRE) -- As Bitcoin continues its bullish momentum in 2025, digital asset investors are turning to DN Miner not just for daily returns — but for risk diversification. DN Miner, a leader in AI-optimized cloud mining, is …

Olas Joins ETH Lisbon 2025 to Empower Developers with $15,000 Bounty and AI Agent Innovation

Olas Joins ETH Lisbon 2025 to Empower Developers with $15,000 Bounty and AI Agent Innovation

Lisbon, Portugal , May 05, 2025 (GLOBE NEWSWIRE) -- Olas, a platform for co-owning autonomous AI agents and named as one of the "top DeFAI projects" by Coin Codex, announces its participation in ETH Lisbon 2025 as a sponsor of the ENCODE Hackathon. Taking …

Datadog Acquires Eppo to Expand Its AI, Product Analytics, Experimentation and Feature Flag Capabilities

Datadog Acquires Eppo to Expand Its AI, Product Analytics, Experimentation and Feature Flag Capabilities

NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) --  Datadog, Inc. (NASDAQ: DDOG), the monitoring and security platform for cloud applications, today announced it has acquired Eppo, a feature flagging and experimentation platform, which will tightly integrate with …

Moleculin Bolsters Annamycin Intellectual Property Portfolio with Granting of Two New U.S. Patents

Moleculin Bolsters Annamycin Intellectual Property Portfolio with Granting of Two New U.S. Patents

Company continues to expand global IP coverage and claims to major markets, now extending to June 2040  HOUSTON, May 05, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company …

Gene Therapy Market to Hit US$36.55 Billion by 2032 with 19.4% CAGR | MarketsandMarkets™

Gene Therapy Market to Hit US$36.55 Billion by 2032 with 19.4% CAGR | MarketsandMarkets™

Delray Beach, FL, May 05, 2025 (GLOBE NEWSWIRE) -- The global Gene Therapy market, valued at US$7.21 billion in 2023, is forecasted to grow at a robust CAGR of 19.4%, reaching US$8.85 billion in 2024 and an impressive US$36.55 billion by 2032. Market …

Rose Hill Life Sciences Appoints Biopharma Veteran Jama Pitman as Strategic Advisor

Rose Hill Life Sciences Appoints Biopharma Veteran Jama Pitman as Strategic Advisor

Seasoned pharmaceutical executive to advise on clinical development, regulatory strategy, and commercialization as Company accelerates its psilocybin-based therapeutic programs BOSTON, May 05, 2025 (GLOBE NEWSWIRE) -- Rose Hill Life Sciences (“The Company” …

Rakovina Therapeutics Announces Appointment of Dr. David Kideckel as Chief Financial Officer

Rakovina Therapeutics Announces Appointment of Dr. David Kideckel as Chief Financial Officer

VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered …

Ascendis to Share Its Latest Endocrinology Rare Disease Data at ESPE & ESE 2025

Ascendis to Share Its Latest Endocrinology Rare Disease Data at ESPE & ESE 2025

COPENHAGEN, Denmark, May 05, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will share the latest data from its hypoparathyroidism, achondroplasia, and growth hormone deficiency (GHD) programs during ESPE …

Surfshark becomes the first company to launch privacy-oriented public DNS service

Surfshark becomes the first company to launch privacy-oriented public DNS service

Surfshark, a cybersecurity company, has taken a step further to benefit the privacy community by launching a public DNS (Domain Name System). Unlike the default DNS servers provided by ISPs (Internet Service Providers), which often track and record user …

Assertio Holdings, Inc. to Report First Quarter 2025 Financial Results on May 12, 2025

Assertio Holdings, Inc. to Report First Quarter 2025 Financial Results on May 12, 2025

LAKE FOREST, Ill., May 05, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that it will release first quarter 2025 financial results on Monday, May 12, 2025, after the market close. Additionally …

Werewolf Therapeutics Presents New Preclinical Data Further Characterizing its IL-10 INDUKINE Molecule, WTX-921, for the Treatment of Inflammatory Bowel Disease (IBD) at AAI Annual Meeting

Werewolf Therapeutics Presents New Preclinical Data Further Characterizing its IL-10 INDUKINE Molecule, WTX-921, for the Treatment of Inflammatory Bowel Disease (IBD) at AAI Annual Meeting

- Data reveal WTX-921 is efficacious in a mouse colitis model, resulting in reduced tissue damage and inflammatory cytokine production - - Findings offer a more detailed understanding of WTX-921’s anti-inflammatory impact on the immune landscape in the …

4DMT to Participate in Upcoming Investor Conferences

4DMT to Participate in Upcoming Investor Conferences

EMERYVILLE, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment …

Spero Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on Tuesday, May 13, 2025

Spero Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on Tuesday, May 13, 2025

CAMBRIDGE, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial …

ARS Pharmaceuticals Announces Conference Call and Webcast for its First Quarter 2025 Financial Results

ARS Pharmaceuticals Announces Conference Call and Webcast for its First Quarter 2025 Financial Results

SAN DIEGO, May 05, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from allergic reactions that could lead to anaphylaxis, …

Sagitec Awarded MainePERS Project for a Modern Pension Administration System

Sagitec Awarded MainePERS Project for a Modern Pension Administration System

ST. PAUL, Minn., May 05, 2025 (GLOBE NEWSWIRE) -- Sagitec is proud to announce that it has been awarded the Maine Public Employees Retirement System (MainePERS) project. This achievement is a testament to Sagitec's commitment to adhering to the vision that …

Cerence AI and Code Factory Collaborate to Bring Voice-Powered Interaction to Self-Service Kiosks

Cerence AI and Code Factory Collaborate to Bring Voice-Powered Interaction to Self-Service Kiosks

BURLINGTON, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today announced an expanded collaboration with its long-time partner and distributor, …

Werewolf Therapeutics to Participate in Upcoming Investor Conferences

Werewolf Therapeutics to Participate in Upcoming Investor Conferences

WATERTOWN, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate …

Opus Genetics Announces Presentation of OPGX-LCA5 Gene Therapy Data at ARVO; 12 Month Phase 1/2 Results Support Potential to Restore to Meaningful Vision

Opus Genetics Announces Presentation of OPGX-LCA5 Gene Therapy Data at ARVO; 12 Month Phase 1/2 Results Support Potential to Restore to Meaningful Vision

Improvements in subjective and objective measures of efficacy observed at six months persisted for one year in patients with severe vision impairment from inherited retinal degeneration due to mutations in the LCA5 gene Administration of OPGx-LCA5 by …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service